Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sai Pallavi Pradeep

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Molecular Therapy. Nucleic Acids|March 11, 2026
Enhanced liver-targeted delivery with ribofuranose-based GalNAc conjugatesSai Pallavi Pradeep, Ruchi Ruchi, Raman Bahal
RNA (New York, N.Y.)|January 18, 2023
Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeuticsSai Pallavi Pradeep, Shipra Malik, Frank J Slack, et al.
Molecular Therapy. Nucleic Acids|April 24, 2026
Investigating the role of mimosine-induced genotoxic stress through DNA repair profilingSai Pallavi Pradeep, Suraj Kalaria, Peter M Glazer, et al.
Molecular Therapy. Nucleic Acids|January 15, 2026
Combining anti-gene γPNA with small molecules and RNA inhibitors: A strategy to enhance anti-tumor efficacySai Pallavi Pradeep, Brooke Elizabeth DiVasto, Peter M Glazer, et al.
Cell Reports. Physical Science|October 18, 2024
Enhancing RNA inhibitory activity using clamp-G-modified nucleobasesSai Pallavi Pradeep, Vikas Kumar, Shipra Malik, et al.
NPJ Precision Oncology|June 19, 2026
Sequence-specific targeting of VEGFA genomic DNA to inhibit tumor growthAngana De, Sai Pallavi Pradeep, Paroma Deb, et al.
Pharmaceutical Research|September 7, 2022
Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell LinesKarishma Dhuri, Sai Pallavi Pradeep, Jason Shi, et al.
Cell Reports. Medicine|January 6, 2024
Antitumor efficacy of a sequence-specific DNA-targeted γPNA-based c-Myc inhibitorShipra Malik, Sai Pallavi Pradeep, Vikas Kumar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
CD38+CD27-TNF-α + on Mtb-specific CD4+ T Cells Is a Robust Biomarker for Tuberculosis DiagnosisMuthya Pragun Acharya, Sai Pallavi Pradeep, Venkataramappa Srinivasa Murthy, et al.
Frontiers in Immunology|August 2, 2021
Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue PatientsSai Pallavi Pradeep, Pooja Hoovina Venkatesh, Nageswar R Manchala, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecular Therapy. Nucleic Acids|March 11, 2026
Enhanced liver-targeted delivery with ribofuranose-based GalNAc conjugatesSai Pallavi Pradeep, Ruchi Ruchi, Raman Bahal
RNA (New York, N.Y.)|January 18, 2023
Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeuticsSai Pallavi Pradeep, Shipra Malik, Frank J Slack, et al.
Molecular Therapy. Nucleic Acids|April 24, 2026
Investigating the role of mimosine-induced genotoxic stress through DNA repair profilingSai Pallavi Pradeep, Suraj Kalaria, Peter M Glazer, et al.
Molecular Therapy. Nucleic Acids|January 15, 2026
Combining anti-gene γPNA with small molecules and RNA inhibitors: A strategy to enhance anti-tumor efficacySai Pallavi Pradeep, Brooke Elizabeth DiVasto, Peter M Glazer, et al.
Cell Reports. Physical Science|October 18, 2024
Enhancing RNA inhibitory activity using clamp-G-modified nucleobasesSai Pallavi Pradeep, Vikas Kumar, Shipra Malik, et al.
NPJ Precision Oncology|June 19, 2026
Sequence-specific targeting of VEGFA genomic DNA to inhibit tumor growthAngana De, Sai Pallavi Pradeep, Paroma Deb, et al.
Pharmaceutical Research|September 7, 2022
Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell LinesKarishma Dhuri, Sai Pallavi Pradeep, Jason Shi, et al.
Cell Reports. Medicine|January 6, 2024
Antitumor efficacy of a sequence-specific DNA-targeted γPNA-based c-Myc inhibitorShipra Malik, Sai Pallavi Pradeep, Vikas Kumar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
CD38+CD27-TNF-α + on Mtb-specific CD4+ T Cells Is a Robust Biomarker for Tuberculosis DiagnosisMuthya Pragun Acharya, Sai Pallavi Pradeep, Venkataramappa Srinivasa Murthy, et al.
Frontiers in Immunology|August 2, 2021
Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue PatientsSai Pallavi Pradeep, Pooja Hoovina Venkatesh, Nageswar R Manchala, et al.
Pageof 2